Ligand Pharmaceuticals (LGND) Receivables - Net (2010 - 2026)
Ligand Pharmaceuticals' Receivables - Net was $67.01 million in Q2 2026, up 62.3% from $41.29 million a year earlier and up 25.5% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Receivables - Net (2010 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Ligand Pharmaceuticals came in at $59.6 million, up 55.3% from FY2024.
- Receivables - Net has now increased for three consecutive years, with a five-year compound annual growth rate of 1.0% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $38.38 million in FY2024 (+16.6%), $32.92 million in FY2023 (+8.2%), $30.42 million in FY2022 (-64.4%) and $85.45 million in FY2021 (+50.3%).
- The Q2 2026 figure marks the highest quarterly Receivables - Net since Q4 2021.
- Compared with a year earlier, Receivables - Net has increased for seven straight quarters, with growth averaging 35.2% over the last eight quarters.
- The best year-over-year quarter for Receivables - Net over five years was Q3 2021 (growth of 95.5%); the worst was Q4 2022 (a decline of 64.4%).
- Per Business Quant data, LGND's Receivables - Net in the three quarters before Q2 2026 was $53.38 million (Q1 2026), $59.6 million (Q4 2025) and $57.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Ligand Pharmaceuticals | 6.26 Bn | 2.72 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.01 Mn |
| Mar 31, 2026 | 53.38 Mn |
| Dec 31, 2025 | 59.60 Mn |
| Sep 30, 2025 | 57.56 Mn |
| Jun 30, 2025 | 41.29 Mn |
| Mar 31, 2025 | 38.49 Mn |
| Dec 31, 2024 | 38.38 Mn |
| Sep 30, 2024 | 34.32 Mn |
| Jun 30, 2024 | 37.48 Mn |
| Mar 31, 2024 | 28.44 Mn |
| Dec 31, 2023 | 32.92 Mn |
| Sep 30, 2023 | 36.00 Mn |
| Jun 30, 2023 | 27.99 Mn |
| Mar 31, 2023 | 29.19 Mn |
| Dec 31, 2022 | 30.42 Mn |
| Sep 30, 2022 | 65.17 Mn |
| Jun 30, 2022 | 62.31 Mn |
| Mar 31, 2022 | 41.80 Mn |
| Dec 31, 2021 | 85.45 Mn |
| Sep 30, 2021 | 64.34 Mn |
API Access
Ligand Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();